New registry to monitor eczema drugs in 1,500 adolescents
NCT ID NCT06238765
First seen Feb 15, 2026 · Last updated May 18, 2026 · Updated 17 times
Summary
This study is a registry that will follow about 1,500 teenagers (ages 12-15) with moderate-to-severe atopic dermatitis (eczema) to see how well their treatments work and if there are any side effects. Participants are already starting or have recently started a new medication for their condition. The goal is to better understand the disease and its management in real-world settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CorEvitas, LLC
RECRUITINGWaltham, Massachusetts, 02451, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.